Gretchen Williamson

发表

Efficacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study

J. Rosenstock, D. D’Alessio, J. Frias, 2019, Diabetes Care.

Ef ﬁ cacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study

J. Rosenstock, J. Frias, J. Pettus, 2019 .